[go: up one dir, main page]

AU2002218180A1 - Mammalian nuclear receptor cofactor cf6 and methods of use - Google Patents

Mammalian nuclear receptor cofactor cf6 and methods of use

Info

Publication number
AU2002218180A1
AU2002218180A1 AU2002218180A AU1818002A AU2002218180A1 AU 2002218180 A1 AU2002218180 A1 AU 2002218180A1 AU 2002218180 A AU2002218180 A AU 2002218180A AU 1818002 A AU1818002 A AU 1818002A AU 2002218180 A1 AU2002218180 A1 AU 2002218180A1
Authority
AU
Australia
Prior art keywords
methods
nuclear receptor
mammalian nuclear
receptor cofactor
cofactor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218180A
Inventor
Georg Casari
David Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sygnis Pharma AG
Original Assignee
Lion Bioscience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Bioscience AG filed Critical Lion Bioscience AG
Publication of AU2002218180A1 publication Critical patent/AU2002218180A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002218180A 2000-09-22 2001-09-17 Mammalian nuclear receptor cofactor cf6 and methods of use Abandoned AU2002218180A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00120722 2000-09-22
EP00120722.4 2000-09-22
PCT/EP2001/010744 WO2002024728A2 (en) 2000-09-22 2001-09-17 Mammalian nuclear receptor cofactor cf6 and methods of use

Publications (1)

Publication Number Publication Date
AU2002218180A1 true AU2002218180A1 (en) 2002-04-02

Family

ID=8169916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218180A Abandoned AU2002218180A1 (en) 2000-09-22 2001-09-17 Mammalian nuclear receptor cofactor cf6 and methods of use

Country Status (2)

Country Link
AU (1) AU2002218180A1 (en)
WO (1) WO2002024728A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426411B1 (en) * 1997-05-30 2002-07-30 Dana-Farber Cancer Institute PGC-1, a novel brown fat pparγ coactivator
GB0022670D0 (en) * 2000-09-15 2000-11-01 Astrazeneca Ab Molecules

Also Published As

Publication number Publication date
WO2002024728A3 (en) 2002-11-07
WO2002024728A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001265346A1 (en) Artificial antigen presenting cells and methods of use thereof
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2001283492A1 (en) Methods of patterning protein and cell adhesivity
AU2001241474A1 (en) Biosensor compositions and methods of use
AU5444800A (en) LTiGTin vitroLT/iGT cell culture device including cartilage and methods of usingthe same
AU1939801A (en) In situ bioreactors and methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002315168A1 (en) Combination therapy of gamma-interferon and b cell specific antibodies
AU2001292617A1 (en) Mammalian receptor genes and uses
WO2001041823A8 (en) Radioactive compositions and methods of use thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001294556A1 (en) Methods and compositions for the construction and use of fusion libraries
AU2786100A (en) Method of selecting transformed cells and tissues
AU2002230459A1 (en) Cell culture apparatus and methods of use
AU5915300A (en) Unmarked deletion mutants of mycobacteria and methods of using same
AU6162199A (en) Reversibly immortalized hepatocytes and methods of use
AU4014700A (en) Tuberculosis antigens and methods of use therefor
AU2002248051A1 (en) Stabilized biocatalysts and methods of bioconversion using the same
AU1522400A (en) Substituted pyrimidine compositions and methods of use
AU6412599A (en) Oxybutynin formulations and methods of use
AU2001217686A1 (en) Method of establishing cultures of human dendritic cells and use thereof
AU2002218180A1 (en) Mammalian nuclear receptor cofactor cf6 and methods of use
AU2001236965A1 (en) Method and system of user profile generation
AU2002230479A1 (en) Cell culture apparatus and methods of use
AU1660201A (en) Biglycan and related therapeutics and methods of use